-
GenBioPro, which makes a generic form of mifepristone, is suing the FDA seeking to preserve access to the drug amidst ongoing federal litigation.
-
The justices are expected to issue an order on Wednesday in a fast-moving case from Texas in which abortion opponents are seeking to roll back Food and Drug Administration approval of the drug, mifepristone.
-
Florida's abortion legal landscape is getting a shakeup from the six-week ban being signed into law to drugs possibly taken from clinics.
-
Supreme Court Justice Samuel Alito has placed a hold on a lower court ruling that restricts access to the abortion drug mifepristone until Wednesday night.
-
The DOJ and Danco Laboratories filed emergency requests with the court less than two days after an appeals court ruling in a case from Texas that had the effect of tightening the rules under which mifepristone, can be used.
-
Here's what really went down when the FDA originally approved mifepristone in 2000.
-
The Biden administration had asked the higher court to stay a decision from a Texas judge while the appeal plays out.
-
U.S. District Judge Matthew Kacsmaryk issued his decision Friday but ruled it would not take effect for seven days. The Biden administration on Monday asked the New Orleans-based appellate court to extend the pause on the order.
-
A medical ethics expert says a Texas abortion pill ruling is unprecedented because a federal judge "standing in" for regulators could have far-reaching implications beyond mifepristone.
-
A Texas man is suing three women he says helped his ex-wife obtain an abortion "without even his knowledge." Experts say documents related to the case suggest he might have known ahead of time.